<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-124988" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Dysthyroid Optic Neuropathy</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Agarwal</surname>
            <given-names>Ayushi</given-names>
          </name>
          <aff>Guru Nanak Eye Centre, Maulana Azad Medical College</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Khanam</surname>
            <given-names>Samreen</given-names>
          </name>
          <aff>Maulana Azad Medical College, New Delhi</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ayushi Agarwal declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Samreen Khanam declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>31</day>
          <month>10</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-124988.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Dysthyroid optic neuropathy (DON) is a sight-threatening complication of thyroid eye disease (TED), characterized by thyroid-related impairment of visual function, leading to permanent sight loss. To avoid blindness, prompt diagnosis and timely intervention are required. This activity reviews the evaluation and treatment of DON and highlights the role of the interprofessional team in managing patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify&#x000a0;the etiology of dysthyroid optic neuropathy.</p></list-item><list-item><p>Assess&#x000a0;the pathophysiology of dysthyroid optic neuropathy.</p></list-item><list-item><p>Evaluate&#x000a0;the typical clinical features of dysthyroid optic neuropathy.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=124988&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=124988">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-124988.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Dysthyroid optic neuropathy (DON) represents the most dreaded manifestation of thyroid eye disease (TED), one of the most common autoimmune diseases of the orbit.<xref ref-type="bibr" rid="article-124988.r1">[1]</xref>&#x000a0;DON,&#x000a0;previously termed the crowded orbital apex syndrome, is characterized by thyroid-related impairment of optic nerve function that may lead to profound vision loss. The European Group on Graves Orbitopathy (EUGOGO) classifies the severity of TED as mild, moderate-severe, or sight-threatening. Sight-threatening TED, characterized by DON or keratopathy, warrants urgent intervention (see&#x000a0;<bold>Image.&#x000a0;</bold>Left&#x000a0;Corneal&#x000a0;Exposure&#x000a0;Keratopathy&#x000a0;With&#x000a0;Bilateral&#x000a0;Optic&#x000a0;Nerve&#x000a0;Involvement).<xref ref-type="bibr" rid="article-124988.r2">[2]</xref>&#x000a0;DON is a multifactorial entity whose diagnosis is extremely challenging owing to its early subclinical stage, the presence of confounding factors, and alternative causes of sight loss in TED. A thorough evaluation of DON and subsequent timely management are crucial to avoid permanent blindness in TED.</p>
      </sec>
      <sec id="article-124988.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Several etiological factors have been implicated in the progression of TED, which may also be linked to DON. Thyroid status impairment is one of the most important associations. The majority of cases of DON are associated with hyperthyroidism. This can be attributed to the fact that hyperthyroidism is the most common form of thyroid dysfunction in TED.<xref ref-type="bibr" rid="article-124988.r3">[3]</xref>&#x000a0;It is worth noting that hypothyroidism, autoimmune thyroiditis, or even a euthyroid status may be found with DON.&#x000a0;Radio-active Iodine therapy, a well-known risk factor for TED progression, may increase the incidence of DON, although any meaningful evidence is lacking.<xref ref-type="bibr" rid="article-124988.r4">[4]</xref>&#x000a0;Studies have demonstrated smoking as an independent modifiable risk factor for the development of the DON.<xref ref-type="bibr" rid="article-124988.r5">[5]</xref><xref ref-type="bibr" rid="article-124988.r6">[6]</xref><bold>&#x000a0;</bold>A recent study has discovered a correlation between early-onset DON and thyroid-stimulating immunoglobulin positivity.<xref ref-type="bibr" rid="article-124988.r7">[7]</xref>&#x000a0;<bold>&#x000a0;</bold>It has also been shown that in patients with diabetic vasculopathy, especially those on injectable insulin, hypoxia of the optic nerve occurs, leading to subsequent nerve damage.<xref ref-type="bibr" rid="article-124988.r8">[8]</xref>&#x000a0;Such patients of TED with superimposed comorbidities must closely be monitored for the development of optic neuropathy. Previous studies have linked numerous genes to TED's pathogenetic mechanism; however, none are specific to DON.<xref ref-type="bibr" rid="article-124988.r9">[9]</xref></p>
      </sec>
      <sec id="article-124988.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Approximately every 5 in 100 patients with TED progress to sight-threatening optic neuropathy.<xref ref-type="bibr" rid="article-124988.r10">[10]</xref><bold>&#x000a0;</bold>Younger patients are less likely to develop DON than older age groups. It is found that for every 10-year increment in the onset of ophthalmopathy, the risk of developing optic neuropathy increases by approximately 60%.<xref ref-type="bibr" rid="article-124988.r11">[11]</xref>&#x000a0;Increased age at presentation of DON is associated with poorer long-term outcomes.<xref ref-type="bibr" rid="article-124988.r12">[12]</xref>&#x000a0;Although the&#x000a0;White-race population demonstrates female preponderance in TED, DON is more common in males.&#x000a0;Hence, an old male is far more likely to develop DON than a young female.<xref ref-type="bibr" rid="article-124988.r13">[13]</xref><xref ref-type="bibr" rid="article-124988.r14">[14]</xref><xref ref-type="bibr" rid="article-124988.r15">[15]</xref></p>
      </sec>
      <sec id="article-124988.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>There are several hypothesized pathophysiological mechanisms. The most widely accepted theory is the direct mechanical compression of the optic nerve by the edematous extra-ocular muscles and intra-orbital fat, leading to the deceleration of the axonal flow and the resultant ischemia.<xref ref-type="bibr" rid="article-124988.r16">[16]</xref><xref ref-type="bibr" rid="article-124988.r17">[17]</xref><bold>&#x000a0;</bold>The subsequent crowding at the orbital apex also often increases orbital pressure. Substantial evidence to support the above theory can be derived from the fact that the visual acuity and retrobulbar pressure significantly improve after orbital decompression. This surgery relieves the crowding and the congestion in orbit.<xref ref-type="bibr" rid="article-124988.r18">[18]</xref><xref ref-type="bibr" rid="article-124988.r19">[19]</xref><bold>&#x000a0;</bold>The traditional hypothesis of optic nerve inflammation as the implicated mechanism is obsolete due to a lack of strong evidence of inflammatory cells in the histopathological specimen of the optic nerve in patients with suspected or clinically diagnosed DON.<xref ref-type="bibr" rid="article-124988.r20">[20]</xref><bold>&#x000a0;</bold>Stretching of the optic nerve is yet another postulated mechanism of optic neuropathy in TED. Unlike the peripheral nerves, the optic nerve has a regular and uniform organization of nerve fibers. This anatomical difference presumably makes it more vulnerable to damage through circumferential straining.<xref ref-type="bibr" rid="article-124988.r21">[21]</xref><xref ref-type="bibr" rid="article-124988.r22">[22]</xref>&#x000a0;Impaired venous drainage and hypoperfusion of the apical portion of the optic nerve may also contribute to further optic nerve injury.</p>
      </sec>
      <sec id="article-124988.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Besides the clinical features of TED, the most common presenting symptoms specific to DON include blurred vision and impaired perception of color sense.<xref ref-type="bibr" rid="article-124988.r23">[23]</xref><xref ref-type="bibr" rid="article-124988.r24">[24]</xref><xref ref-type="bibr" rid="article-124988.r25">[25]</xref>&#x000a0;In subclinical forms, the patients may even be asymptomatic. A comprehensive clinical examination is required that may reveal a decrease in best-corrected visual acuity, relative afferent pupillary defect in unilateral and asymmetric cases, optic disc edema and hyperemia (acute form), optic atrophy (chronic form), which may or may not be accompanied by features of activity, that is, a Clinical Activity Score of more than 2 out of 7 (EUGOGO 2016 guidelines), restricted extra-ocular movements, proptosis, strabismus, and even ptosis.<xref ref-type="bibr" rid="article-124988.r26">[26]</xref><xref ref-type="bibr" rid="article-124988.r16">[16]</xref></p>
      </sec>
      <sec id="article-124988.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>DON is a controversial disease entity whose diagnostic criteria have not been established. Color vision and contrast sensitivity tests may help detect an early onset DON. Characteristic visual defects include a central or paracentral scotoma. Other patterns include an enlarged blind spot, arcuate or altitudinal scotomas, and inferior defects more common than superior.<xref ref-type="bibr" rid="article-124988.r27">[27]</xref>&#x000a0;The retinal never fiber layer and macular ganglion cell analysis using optical coherent tomography are gaining popularity due to the test's non-invasive, non-contact, and highly reproducible properties.<xref ref-type="bibr" rid="article-124988.r28">[28]</xref>&#x000a0;The clinician must consider electrophysiological assessment to test the integrity of the optic nerve using pattern visual evoked potential signals, which may reveal a decreased amplitude and increased latency of the P-wave.<xref ref-type="bibr" rid="article-124988.r29">[29]</xref>&#x000a0;Radiological evaluation using computed tomography and magnetic resonance imaging plays an important role in DON. Imaging may reveal one or more of the various predictors, which include apical crowding, prolapse of the orbital fat through the superior orbital fissure, increased extra-ocular muscle volume (specifically the medial rectus volume that lies close to the optic nerve), and increased superior ophthalmic vein diameter.</p>
        <p>Several measurements, such as Barrett&#x02019;s Muscle Index (MI), Extra-ocular Muscle Volume/ Orbital Volume (MV/OV), and Crowding Index (CI), have been implicated as reliable indicators of the disease in the literature. MV/OV &#x0003e; 20% has potentially come up as a more predictable index of acuity and field loss compared to MI (MI &#x0003e; 60% is indicative of DON).<xref ref-type="bibr" rid="article-124988.r30">[30]</xref><xref ref-type="bibr" rid="article-124988.r31">[31]</xref><xref ref-type="bibr" rid="article-124988.r32">[32]</xref><xref ref-type="bibr" rid="article-124988.r33">[33]</xref><xref ref-type="bibr" rid="article-124988.r34">[34]</xref>&#x000a0;Color Doppler ultrasonography has detected orbital blood flow changes such as reduced resistivity index and central retinal artery flow velocities in early-onset DON.<xref ref-type="bibr" rid="article-124988.r35">[35]</xref>&#x000a0;However, none of the above parameters is solely diagnostic of DON.&#x000a0;In 2007, Dayan and Dayan proposed a useful diagnostic algorithm.<xref ref-type="bibr" rid="article-124988.r36">[36]</xref>&#x000a0;The initial step is to look for the clinical features suggestive of TED and the presence of damaged visual function, which is indicated by any one of the following: impairment of color vision, diminished visual acuity, disc edema/atrophy, presence of a relative afferent pupillary defect, specific field defects or electrophysiological abnormalities. If none of these features are present, DON is &#x0201c;unlikely.&#x0201d; If present, rule out an alternative etiology of visual loss in TED. If none could be found in the presence of supporting radiological evidence of compression, DON is &#x0201c;likely&#x0201d; to be present. If no radiological evidence is present or an alternative cause is found, but with radiological compression, DON is still &#x0201c;possible.&#x0201d; In the presence of a different etiology of visual impairment without any compressive features on imaging, DON is again &#x0201c;unlikely.&#x0201d; The key message from the hypothesized flowchart is that DON can never be completely ruled out, and a high index of suspicion must always be maintained, especially in cases with subclinical stage, euthyroid presentation, and bilaterally symmetric DON where most of the ancillary tests may give confusing results.</p>
      </sec>
      <sec id="article-124988.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>TED complicated with DON requires aggressive management. The treatment options include medical decompression using corticosteroids, radiotherapy, and surgical decompression. There is no single best treatment option; sometimes, even a combination of the above choices is recommended.<xref ref-type="bibr" rid="article-124988.r37">[37]</xref>&#x000a0;Corticosteroid therapy is the proposed first-line treatment in DON. EUGOGO recommends intravenous methylprednisolone (IVMP) as the immunosuppressant of choice in DON. The regimen states using 500-1000 mg IVMP daily for 3 consecutive days, followed by a repeat dose after 1 week (if needed). If improvement in visual parameters is observed at 2 weeks, the dosage can be tapered, or alternate forms such as oral steroids may be used. This is referred to as medical decompression. Complete visual recovery has been shown to occur in 43% of cases with this regimen.<xref ref-type="bibr" rid="article-124988.r38">[38]</xref><xref ref-type="bibr" rid="article-124988.r39">[39]</xref><xref ref-type="bibr" rid="article-124988.r40">[40]</xref>&#x000a0;It has been shown that almost half of the patients may avoid surgery if treated with IVMP.<xref ref-type="bibr" rid="article-124988.r41">[41]</xref>&#x000a0;At no point in time, should the cumulative dose of IVMP exceed 8g, otherwise, fatal systemic adverse effects may occur such as acute heart failure, liver dysfunction, and even sudden death.<xref ref-type="bibr" rid="article-124988.r42">[42]</xref><xref ref-type="bibr" rid="article-124988.r43">[43]</xref>&#x000a0;</p>
        <p>The clinician must perform a thorough clinical assessment and conduct all the baseline investigations, such as blood sugar, liver function tests, serum electrolytes, chest x-rays, electrocardiography, and blood pressure, before administering steroids.&#x000a0;Inadequate response to IVMP is defined as persistent activity and disc edema even after 2 weeks of treatment.<xref ref-type="bibr" rid="article-124988.r44">[44]</xref>&#x000a0;In this scenario, urgent surgical decompression of the orbit is recommended. In general, orbital decompression is advised only after achieving at least 6 months of euthyroid status in inactive TED. DON is probably the only indication of an urgent orbital decompression in the active stage of the disease.<xref ref-type="bibr" rid="article-124988.r26">[26]</xref>&#x000a0;Surgical decompression provides excellent outcomes with visual improvement in 70&#x000a0;to 85% of cases.<xref ref-type="bibr" rid="article-124988.r45">[45]</xref><xref ref-type="bibr" rid="article-124988.r1">[1]</xref>&#x000a0;It leads to the expansion of the bony volume and a relative decrease in the soft tissue volume so that the apical structures decompress. This can be achieved via infero-medial wall decompression, lateral wall decompression, or even a combination of the two (3-wall), with or without fat decompression.&#x000a0;The inferomedial orbit can be approached via the trans-antral, trans-cutaneous, trans-caruncular, or endoscopically through the nasal approach. In the trans-antral approach, the incision is given along the buccal sulcus, and the anterior wall of the maxilla is removed.</p>
        <p>A high number of cases with postoperative diplopia (66%) outranks its rate of success (90%). Alveolar nerve hypoesthesia, cerebrospinal fluid leak, and entropion are rare but possible complications.<xref ref-type="bibr" rid="article-124988.r46">[46]</xref>&#x000a0;The trans-cutaneous approach involves giving a subciliary incision along the lower eyelid.&#x000a0;A trans-cutaneous Lynch incision, a 3 cm curvilinear incision, is given along the nasal area adjacent to the medial canthus. However, this approach often results in a webbed scar and may potentially damage the underlying lacrimal system. A modification involving a smaller-sized (1.5cm) incision results in minimal webbing and minimizes the risk of iatrogenic damage. Another popular approach is the "swinging lid crease" incision, which gives an excellent view of the inferomedial orbit and provides better visualization of the lateral wall and the orbital fat.<xref ref-type="bibr" rid="article-124988.r47">[47]</xref><xref ref-type="bibr" rid="article-124988.r48">[48]</xref><xref ref-type="bibr" rid="article-124988.r49">[49]</xref>&#x000a0;A trans-caruncular approach provides safe, quick, and graded access to the apical area, thus lowering the chances of postoperative diplopia.<xref ref-type="bibr" rid="article-124988.r50">[50]</xref><xref ref-type="bibr" rid="article-124988.r51">[51]</xref>&#x000a0;Another safe approach with low rates of postoperative diplopia is lateral wall decompression, which includes removing the deep lateral wall using a drill or aspirator.<xref ref-type="bibr" rid="article-124988.r52">[52]</xref>&#x000a0;</p>
        <p>In fat-centric TED complicated with DON, fat decompression alone, via transconjunctival or transcutaneous approach, can alleviate compression.<xref ref-type="bibr" rid="article-124988.r22">[22]</xref>&#x000a0;A novel approach describing a combination of endoscopic trans-ethmoidal medial orbital wall decompression and endoscopic trans-ethmoidal fat decompression has been reported in the literature with low rates of postoperative diplopia that resolved within a few months.<xref ref-type="bibr" rid="article-124988.r53">[53]</xref>&#x000a0;Fractionated radiotherapy (2000 rad per eye in ten doses over 10 days) is indicated in patients refractory to medical and surgical decompression or patients with several comorbidities, such as hypertension and diabetic retinopathy.<xref ref-type="bibr" rid="article-124988.r54">[54]</xref>&#x000a0;However, the scarcity of evidence-based data regarding its definite use in DON makes it debatable. The use of steroid-sparing immunosuppressive agents such as adalimumab, tocilizumab, and teprotumumab, specifically for DON, is yet to be established.&#x000a0;</p>
      </sec>
      <sec id="article-124988.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnoses of DON include other causes of sight-threatening TED, such as ocular surface diseases.&#x000a0;Alternative&#x000a0;etiologies of optic neuropathy, such as those due to toxic and nutritional causes, must be ruled out, specifically in the presence of central and paracentral scotomas. Unilateral disc edema with the enlarged blind spot and electrophysiological changes may also raise the suspicion of optic neuritis. It is not uncommon to have secondary glaucoma in TED that may cause visual acuity changes, arcuate field defects, retinal never fiber layer defects, and ocular blood flow changes. A meticulous history, clinical evaluation, and dedicated investigative workup help to differentiate each of the above from DON.</p>
      </sec>
      <sec id="article-124988.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>It is imperative to understand that the prognosis of DON largely depends upon whether the treatment was received and the stage or time at which the intervention was initiated. A timely intervention in DON saves vision, with full recovery in about 70% of cases. The additional positive prognosticating factors are young age and an elevated Clinical Activity Score.<xref ref-type="bibr" rid="article-124988.r45">[45]</xref><xref ref-type="bibr" rid="article-124988.r12">[12]</xref></p>
      </sec>
      <sec id="article-124988.s11" sec-type="Complications">
        <title>Complications</title>
        <p>More than a disease, DON is itself the gravest complication of TED. Misdiagnosed or left untreated, it leads to permanent loss of visual function. It not only leads to visual disability but also results in major psychosocial trauma.</p>
      </sec>
      <sec id="article-124988.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Elimination of modifiable risk factors and prompt restoration of euthyroidism is indispensable in every patient of TED. Once the disease has progressed to DON, the patients must be counseled to seek treatment immediately after explaining the risks and benefits. Strict metabolic control and frequent ophthalmological and systemic check-ups must be encouraged for a better prognosis.</p>
      </sec>
      <sec id="article-124988.s13" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>The occurrence of DON in TED cannot be prevented, but, to a significant extent, the subsequent blindness is avoidable. A systemic multidisciplinary approach is crucial for detecting the subclinical form of DON in patients with thyroid-related ophthalmopathy. A clinician must maintain a low threshold for an aggressive patient work-up.</p>
      </sec>
      <sec id="article-124988.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Every healthcare institution must be motivated to equip themselves with a joint, multidisciplinary &#x0201c;Thyroid Clinic&#x0201d; comprising at least an ophthalmologist and an endocrinologist.&#x000a0;This interprofessional approach is highly encouraged as this not only enhances the management outcomes but also reduces the burden of healthcare costs on these patients, especially in lower-to-middle-income countries. Owing to the autoimmune nature of the disease, the patients must be counseled regarding the need for a lifelong follow-up. Randomized multi-center trials&#x000a0;are needed&#x000a0;to understand the exact etiopathogenesis of DON, the role of steroid-sparing immunosuppressive drugs, especially in co-morbid conditions, and alternate surgical approaches to maximize healthcare outcomes and enhance the patient's quality of life.</p>
      </sec>
      <sec id="article-124988.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=124988&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=124988">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/hormones-and-body-chemistry/dysthyroid-optic-neuropathy/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=124988">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/124988/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=124988">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-124988.s16">
        <fig id="article-124988.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Left Corneal Exposure Keratopathy With Bilateral Optic Nerve Involvement. Left corneal exposure keratopathy with bilateral optic nerve involvement in a 50-year-old male patient with Graves Disease. Contributed by A Agarwal, MBBS</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="DON" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-124988.s17">
        <title>References</title>
        <ref id="article-124988.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dolman</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Dysthyroid optic neuropathy: evaluation and management.</article-title>
            <source>J Endocrinol Invest</source>
            <year>2021</year>
            <month>Mar</month>
            <volume>44</volume>
            <issue>3</issue>
            <fpage>421</fpage>
            <page-range>421-429</page-range>
            <pub-id pub-id-type="pmid">32729049</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bartalena</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Baldeschi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Dickinson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Eckstein</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kendall-Taylor</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Marcocci</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mourits</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Perros</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Boboridis</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Boschi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Curr&#x000f2;</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Daumerie</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kahaly</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Krassas</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Lane</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Lazarus</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Marin&#x000f2;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nardi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Neoh</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Orgiazzi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pearce</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pinchera</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pitz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Salvi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sivelli</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Stahl</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>von Arx</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Wiersinga</surname>
                <given-names>WM</given-names>
              </name>
              <collab>European Group on Graves' Orbitopathy (EUGOGO)</collab>
            </person-group>
            <article-title>Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO.</article-title>
            <source>Eur J Endocrinol</source>
            <year>2008</year>
            <month>Mar</month>
            <volume>158</volume>
            <issue>3</issue>
            <fpage>273</fpage>
            <page-range>273-85</page-range>
            <pub-id pub-id-type="pmid">18299459</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bartley</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Fatourechi</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Kadrmas</surname>
                <given-names>EF</given-names>
              </name>
              <name>
                <surname>Jacobsen</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Ilstrup</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Garrity</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Gorman</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>Clinical features of Graves' ophthalmopathy in an incidence cohort.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1996</year>
            <month>Mar</month>
            <volume>121</volume>
            <issue>3</issue>
            <fpage>284</fpage>
            <page-range>284-90</page-range>
            <pub-id pub-id-type="pmid">8597271</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bahn</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>Graves' ophthalmopathy.</article-title>
            <source>N Engl J Med</source>
            <year>2010</year>
            <month>Feb</month>
            <day>25</day>
            <volume>362</volume>
            <issue>8</issue>
            <fpage>726</fpage>
            <page-range>726-38</page-range>
            <pub-id pub-id-type="pmid">20181974</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wiersinga</surname>
                <given-names>WM</given-names>
              </name>
            </person-group>
            <article-title>Management of Graves' ophthalmopathy.</article-title>
            <source>Nat Clin Pract Endocrinol Metab</source>
            <year>2007</year>
            <month>May</month>
            <volume>3</volume>
            <issue>5</issue>
            <fpage>396</fpage>
            <page-range>396-404</page-range>
            <pub-id pub-id-type="pmid">17452966</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Yoon</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Risk factors associated with the severity of thyroid-associated orbitopathy in Korean patients.</article-title>
            <source>Korean J Ophthalmol</source>
            <year>2010</year>
            <month>Oct</month>
            <volume>24</volume>
            <issue>5</issue>
            <fpage>267</fpage>
            <page-range>267-73</page-range>
            <pub-id pub-id-type="pmid">21052505</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ponto</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Diana</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Binder</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Matheis</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Pitz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pfeiffer</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kahaly</surname>
                <given-names>GJ</given-names>
              </name>
            </person-group>
            <article-title>Thyroid-stimulating immunoglobulins indicate the onset of dysthyroid optic neuropathy.</article-title>
            <source>J Endocrinol Invest</source>
            <year>2015</year>
            <month>Jul</month>
            <volume>38</volume>
            <issue>7</issue>
            <fpage>769</fpage>
            <page-range>769-77</page-range>
            <pub-id pub-id-type="pmid">25736545</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Blandford</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Chundury</surname>
                <given-names>RV</given-names>
              </name>
              <name>
                <surname>Perry</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Dysthyroid optic neuropathy: update on pathogenesis, diagnosis, and management.</article-title>
            <source>Expert Rev Ophthalmol</source>
            <year>2017</year>
            <volume>12</volume>
            <issue>2</issue>
            <fpage>111</fpage>
            <page-range>111-121</page-range>
            <pub-id pub-id-type="pmid">28775762</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stan</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Bahn</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>Risk factors for development or deterioration of Graves' ophthalmopathy.</article-title>
            <source>Thyroid</source>
            <year>2010</year>
            <month>Jul</month>
            <volume>20</volume>
            <issue>7</issue>
            <fpage>777</fpage>
            <page-range>777-83</page-range>
            <pub-id pub-id-type="pmid">20578901</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lazarus</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology of Graves' orbitopathy (GO) and relationship with thyroid disease.</article-title>
            <source>Best Pract Res Clin Endocrinol Metab</source>
            <year>2012</year>
            <month>Jun</month>
            <volume>26</volume>
            <issue>3</issue>
            <fpage>273</fpage>
            <page-range>273-9</page-range>
            <pub-id pub-id-type="pmid">22632364</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khong</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Finch</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>De Silva</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Rylander</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Craig</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Selva</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ebeling</surname>
                <given-names>PR</given-names>
              </name>
            </person-group>
            <article-title>Risk Factors for Graves' Orbitopathy; the Australian Thyroid-Associated Orbitopathy Research (ATOR) Study.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2016</year>
            <month>Jul</month>
            <volume>101</volume>
            <issue>7</issue>
            <fpage>2711</fpage>
            <page-range>2711-20</page-range>
            <pub-id pub-id-type="pmid">27055083</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mi&#x0015b;kiewicz</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rutkowska</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Jab&#x00142;o&#x00144;ska</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Krzeski</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Trautsolt-Jeziorska</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>K&#x00119;cik</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Milczarek-Banach</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pirko-Kotela</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Samsel</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bednarczuk</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Complete recovery of visual acuity as the main goal of treatment in patients with dysthyroid optic neuropathy.</article-title>
            <source>Endokrynol Pol</source>
            <year>2016</year>
            <volume>67</volume>
            <issue>2</issue>
            <fpage>166</fpage>
            <page-range>166-73</page-range>
            <pub-id pub-id-type="pmid">26884288</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Neigel</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Rootman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Belkin</surname>
                <given-names>RI</given-names>
              </name>
              <name>
                <surname>Nugent</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Drance</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Beattie</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Spinelli</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Dysthyroid optic neuropathy. The crowded orbital apex syndrome.</article-title>
            <source>Ophthalmology</source>
            <year>1988</year>
            <month>Nov</month>
            <volume>95</volume>
            <issue>11</issue>
            <fpage>1515</fpage>
            <page-range>1515-21</page-range>
            <pub-id pub-id-type="pmid">3211460</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Trobe</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Glaser</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Laflamme</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Dysthyroid optic neuropathy. Clinical profile and rationale for management.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1978</year>
            <month>Jul</month>
            <volume>96</volume>
            <issue>7</issue>
            <fpage>1199</fpage>
            <page-range>1199-1209</page-range>
            <pub-id pub-id-type="pmid">666628</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Perros</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Crombie</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Matthews</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Kendall-Taylor</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Age and gender influence the severity of thyroid-associated ophthalmopathy: a study of 101 patients attending a combined thyroid-eye clinic.</article-title>
            <source>Clin Endocrinol (Oxf)</source>
            <year>1993</year>
            <month>Apr</month>
            <volume>38</volume>
            <issue>4</issue>
            <fpage>367</fpage>
            <page-range>367-72</page-range>
            <pub-id pub-id-type="pmid">8319368</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McKeag</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lane</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lazarus</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Baldeschi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Boboridis</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Dickinson</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Hullo</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Kahaly</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Krassas</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Marcocci</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Marin&#x000f2;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mourits</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Nardi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Neoh</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Orgiazzi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Perros</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pinchera</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pitz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Prummel</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Sartini</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Wiersinga</surname>
                <given-names>WM</given-names>
              </name>
              <collab>European Group on Graves' Orbitopathy (EUGOGO)</collab>
            </person-group>
            <article-title>Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) survey.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2007</year>
            <month>Apr</month>
            <volume>91</volume>
            <issue>4</issue>
            <fpage>455</fpage>
            <page-range>455-8</page-range>
            <pub-id pub-id-type="pmid">17035276</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Giaconi</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Kazim</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rho</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Pfaff</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>CT scan evidence of dysthyroid optic neuropathy.</article-title>
            <source>Ophthalmic Plast Reconstr Surg</source>
            <year>2002</year>
            <month>May</month>
            <volume>18</volume>
            <issue>3</issue>
            <fpage>177</fpage>
            <page-range>177-82</page-range>
            <pub-id pub-id-type="pmid">12021647</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Otto</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Koornneef</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mourits</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Deen-van Leeuwen</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Retrobulbar pressures measured during surgical decompression of the orbit.</article-title>
            <source>Br J Ophthalmol</source>
            <year>1996</year>
            <month>Dec</month>
            <volume>80</volume>
            <issue>12</issue>
            <fpage>1042</fpage>
            <page-range>1042-5</page-range>
            <pub-id pub-id-type="pmid">9059266</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Riemann</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Kosmorsky</surname>
                <given-names>GS</given-names>
              </name>
            </person-group>
            <article-title>Direct orbital manometry in patients with thyroid-associated orbitopathy.</article-title>
            <source>Ophthalmology</source>
            <year>1999</year>
            <month>Jul</month>
            <volume>106</volume>
            <issue>7</issue>
            <fpage>1296</fpage>
            <page-range>1296-302</page-range>
            <pub-id pub-id-type="pmid">10406609</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Day</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Carroll</surname>
                <given-names>FD</given-names>
              </name>
            </person-group>
            <article-title>Corticosteroids in the treatment of optic nerve involvement associated with thyroid dysfunction.</article-title>
            <source>Trans Am Ophthalmol Soc</source>
            <year>1967</year>
            <volume>65</volume>
            <fpage>41</fpage>
            <page-range>41-51</page-range>
            <pub-id pub-id-type="pmid">5630622</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Soni</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>LN</given-names>
              </name>
            </person-group>
            <article-title>Visual neuropraxia and progressive vision loss from thyroid-associated stretch optic neuropathy.</article-title>
            <source>Eur J Ophthalmol</source>
            <year>2010</year>
            <season>Mar-Apr</season>
            <volume>20</volume>
            <issue>2</issue>
            <fpage>429</fpage>
            <page-range>429-36</page-range>
            <pub-id pub-id-type="pmid">20037894</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kazim</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Trokel</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Acaroglu</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Elliott</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Reversal of dysthyroid optic neuropathy following orbital fat decompression.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2000</year>
            <month>Jun</month>
            <volume>84</volume>
            <issue>6</issue>
            <fpage>600</fpage>
            <page-range>600-5</page-range>
            <pub-id pub-id-type="pmid">10837384</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saeed</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Tavakoli Rad</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bisschop</surname>
                <given-names>PHLT</given-names>
              </name>
            </person-group>
            <article-title>Dysthyroid Optic Neuropathy.</article-title>
            <source>Ophthalmic Plast Reconstr Surg</source>
            <year>2018</year>
            <season>Jul/Aug</season>
            <volume>34</volume>
            <issue>4S Suppl 1</issue>
            <fpage>S60</fpage>
            <page-range>S60-S67</page-range>
            <pub-id pub-id-type="pmid">29927882</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dolman</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Evaluating Graves' orbitopathy.</article-title>
            <source>Best Pract Res Clin Endocrinol Metab</source>
            <year>2012</year>
            <month>Jun</month>
            <volume>26</volume>
            <issue>3</issue>
            <fpage>229</fpage>
            <page-range>229-48</page-range>
            <pub-id pub-id-type="pmid">22632361</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wong</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Dickinson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Perros</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Dayan</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Veeramani</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Morris</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Foot</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Clarke</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>A British Ophthalmological Surveillance Unit (BOSU) study into dysthyroid optic neuropathy in the United Kingdom.</article-title>
            <source>Eye (Lond)</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>32</volume>
            <issue>10</issue>
            <fpage>1555</fpage>
            <page-range>1555-1562</page-range>
            <pub-id pub-id-type="pmid">29915191</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bartalena</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Baldeschi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Boboridis</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Eckstein</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kahaly</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Marcocci</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Perros</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Salvi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wiersinga</surname>
                <given-names>WM</given-names>
              </name>
              <collab>European Group on Graves' Orbitopathy (EUGOGO)</collab>
            </person-group>
            <article-title>The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy.</article-title>
            <source>Eur Thyroid J</source>
            <year>2016</year>
            <month>Mar</month>
            <volume>5</volume>
            <issue>1</issue>
            <fpage>9</fpage>
            <page-range>9-26</page-range>
            <pub-id pub-id-type="pmid">27099835</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Choi</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Oropesa</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Callahan</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Glass</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Teo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cestari</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Kazim</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Freitag</surname>
                <given-names>SK</given-names>
              </name>
            </person-group>
            <article-title>Patterns of visual field changes in thyroid eye disease.</article-title>
            <source>Orbit</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>36</volume>
            <issue>4</issue>
            <fpage>201</fpage>
            <page-range>201-207</page-range>
            <pub-id pub-id-type="pmid">28453366</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Micieli</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Newman</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Biousse</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>The role of optical coherence tomography in the evaluation of compressive optic neuropathies.</article-title>
            <source>Curr Opin Neurol</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>32</volume>
            <issue>1</issue>
            <fpage>115</fpage>
            <page-range>115-123</page-range>
            <pub-id pub-id-type="pmid">30418197</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Iao</surname>
                <given-names>TWU</given-names>
              </name>
              <name>
                <surname>Rong</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Ling</surname>
                <given-names>AN</given-names>
              </name>
              <name>
                <surname>Brel&#x000e9;n</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Chong</surname>
                <given-names>KKL</given-names>
              </name>
            </person-group>
            <article-title>Electrophysiological Studies in Thyroid Associated Orbitopathy: A Systematic Review.</article-title>
            <source>Sci Rep</source>
            <year>2017</year>
            <month>Sep</month>
            <day>21</day>
            <volume>7</volume>
            <issue>1</issue>
            <fpage>12108</fpage>
            <pub-id pub-id-type="pmid">28935968</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Monteiro</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Gon&#x000e7;alves</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Silva</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>Moura</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Ribeiro</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Gebrim</surname>
                <given-names>EM</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic ability of Barrett's index to detect dysthyroid optic neuropathy using multidetector computed tomography.</article-title>
            <source>Clinics (Sao Paulo)</source>
            <year>2008</year>
            <month>Jun</month>
            <volume>63</volume>
            <issue>3</issue>
            <fpage>301</fpage>
            <page-range>301-6</page-range>
            <pub-id pub-id-type="pmid">18568237</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barrett</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Glatt</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Burde</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Gado</surname>
                <given-names>MH</given-names>
              </name>
            </person-group>
            <article-title>Optic nerve dysfunction in thyroid eye disease: CT.</article-title>
            <source>Radiology</source>
            <year>1988</year>
            <month>May</month>
            <volume>167</volume>
            <issue>2</issue>
            <fpage>503</fpage>
            <page-range>503-7</page-range>
            <pub-id pub-id-type="pmid">3357962</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nugent</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Belkin</surname>
                <given-names>RI</given-names>
              </name>
              <name>
                <surname>Neigel</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Rootman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Robertson</surname>
                <given-names>WD</given-names>
              </name>
              <name>
                <surname>Spinelli</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Graeb</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>Graves orbitopathy: correlation of CT and clinical findings.</article-title>
            <source>Radiology</source>
            <year>1990</year>
            <month>Dec</month>
            <volume>177</volume>
            <issue>3</issue>
            <fpage>675</fpage>
            <page-range>675-82</page-range>
            <pub-id pub-id-type="pmid">2243967</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Birchall</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Goodall</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Noble</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Jackson</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Graves ophthalmopathy: intracranial fat prolapse on CT images as an indicator of optic nerve compression.</article-title>
            <source>Radiology</source>
            <year>1996</year>
            <month>Jul</month>
            <volume>200</volume>
            <issue>1</issue>
            <fpage>123</fpage>
            <page-range>123-7</page-range>
            <pub-id pub-id-type="pmid">8657899</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Regensburg</surname>
                <given-names>NI</given-names>
              </name>
              <name>
                <surname>Wiersinga</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>van Velthoven</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Berendschot</surname>
                <given-names>TT</given-names>
              </name>
              <name>
                <surname>Zonneveld</surname>
                <given-names>FW</given-names>
              </name>
              <name>
                <surname>Baldeschi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Saeed</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mourits</surname>
                <given-names>MP</given-names>
              </name>
            </person-group>
            <article-title>Age and gender-specific reference values of orbital fat and muscle volumes in Caucasians.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2011</year>
            <month>Dec</month>
            <volume>95</volume>
            <issue>12</issue>
            <fpage>1660</fpage>
            <page-range>1660-3</page-range>
            <pub-id pub-id-type="pmid">19955201</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Le&#x00161;in</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rogo&#x00161;i&#x00107;</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Vanjaka Rogo&#x00161;i&#x00107;</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bari&#x00161;i&#x00107;</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Pel&#x0010d;i&#x00107;</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Flow Changes in Orbital Vessels Detected with Color Doppler Ultrasound in Patients with Early Dysthyroid Optic Neuropathy.</article-title>
            <source>Acta Clin Croat</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>57</volume>
            <issue>2</issue>
            <fpage>301</fpage>
            <page-range>301-306</page-range>
            <pub-id pub-id-type="pmid">30431723</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dayan</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Dayan</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Dysthyroid optic neuropathy: a clinical diagnosis or a definable entity?</article-title>
            <source>Br J Ophthalmol</source>
            <year>2007</year>
            <month>Apr</month>
            <volume>91</volume>
            <issue>4</issue>
            <fpage>409</fpage>
            <page-range>409-10</page-range>
            <pub-id pub-id-type="pmid">17372336</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Xu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ye</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>The Therapeutic Effect of Combination of Orbital Decompression Surgery and Methylprednisolone Pulse Therapy on Patients with Bilateral Dysthyroid Optic Neuropathy.</article-title>
            <source>J Ophthalmol</source>
            <year>2020</year>
            <volume>2020</volume>
            <fpage>9323450</fpage>
            <pub-id pub-id-type="pmid">32148948</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wakelkamp</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Baldeschi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Saeed</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mourits</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Prummel</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Wiersinga</surname>
                <given-names>WM</given-names>
              </name>
            </person-group>
            <article-title>Surgical or medical decompression as a first-line treatment of optic neuropathy in Graves' ophthalmopathy? A randomized controlled trial.</article-title>
            <source>Clin Endocrinol (Oxf)</source>
            <year>2005</year>
            <month>Sep</month>
            <volume>63</volume>
            <issue>3</issue>
            <fpage>323</fpage>
            <page-range>323-8</page-range>
            <pub-id pub-id-type="pmid">16117821</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eckstein</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schittkowski</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Esser</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Surgical treatment of Graves' ophthalmopathy.</article-title>
            <source>Best Pract Res Clin Endocrinol Metab</source>
            <year>2012</year>
            <month>Jun</month>
            <volume>26</volume>
            <issue>3</issue>
            <fpage>339</fpage>
            <page-range>339-58</page-range>
            <pub-id pub-id-type="pmid">22632370</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marcocci</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Watt</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Altea</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Rasmussen</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Feldt-Rasmussen</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Orgiazzi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bartalena</surname>
                <given-names>L</given-names>
              </name>
              <collab>European Group of Graves' Orbitopathy</collab>
            </person-group>
            <article-title>Fatal and non-fatal adverse events of glucocorticoid therapy for Graves' orbitopathy: a questionnaire survey among members of the European Thyroid Association.</article-title>
            <source>Eur J Endocrinol</source>
            <year>2012</year>
            <month>Feb</month>
            <volume>166</volume>
            <issue>2</issue>
            <fpage>247</fpage>
            <page-range>247-53</page-range>
            <pub-id pub-id-type="pmid">22058081</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhao</surname>
                <given-names>LQ</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>DY</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Intravenous glucocorticoids therapy in the treatment of Graves' ophthalmopathy: a systematic review and Meta-analysis.</article-title>
            <source>Int J Ophthalmol</source>
            <year>2019</year>
            <volume>12</volume>
            <issue>7</issue>
            <fpage>1177</fpage>
            <page-range>1177-1186</page-range>
            <pub-id pub-id-type="pmid">31341811</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eguchi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Tani</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hirao</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tsuruta</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tokubuchi</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Yamada</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kasaoka</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Teshima</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kakuma</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hiromatsu</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Liver Dysfunction Associated with Intravenous Methylprednisolone Pulse Therapy in Patients with Graves' Orbitopathy.</article-title>
            <source>Int J Endocrinol</source>
            <year>2015</year>
            <volume>2015</volume>
            <fpage>835979</fpage>
            <pub-id pub-id-type="pmid">26221141</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yong</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Chng</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Htoon</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Seah</surname>
                <given-names>LL</given-names>
              </name>
            </person-group>
            <article-title>Safety Profile and Effects of Pulsed Methylprednisolone on Vital Signs in Thyroid Eye Disease.</article-title>
            <source>Int J Endocrinol</source>
            <year>2015</year>
            <volume>2015</volume>
            <fpage>457123</fpage>
            <pub-id pub-id-type="pmid">26681940</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Curr&#x000f2;</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Covelli</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Vannucchi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Campi</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Pirola</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Simonetta</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dazzi</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Guastella</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pignataro</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Beck-Peccoz</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ratiglia</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Salvi</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Therapeutic outcomes of high-dose intravenous steroids in the treatment of dysthyroid optic neuropathy.</article-title>
            <source>Thyroid</source>
            <year>2014</year>
            <month>May</month>
            <volume>24</volume>
            <issue>5</issue>
            <fpage>897</fpage>
            <page-range>897-905</page-range>
            <pub-id pub-id-type="pmid">24417307</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jeon</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Shin</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Woo</surname>
                <given-names>KI</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>YD</given-names>
              </name>
            </person-group>
            <article-title>Clinical profile and visual outcomes after treatment in patients with dysthyroid optic neuropathy.</article-title>
            <source>Korean J Ophthalmol</source>
            <year>2012</year>
            <month>Apr</month>
            <volume>26</volume>
            <issue>2</issue>
            <fpage>73</fpage>
            <page-range>73-9</page-range>
            <pub-id pub-id-type="pmid">22511831</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garrity</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Fatourechi</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Bergstralh</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Bartley</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Beatty</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>DeSanto</surname>
                <given-names>LW</given-names>
              </name>
              <name>
                <surname>Gorman</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>Results of transantral orbital decompression in 428 patients with severe Graves' ophthalmopathy.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1993</year>
            <month>Nov</month>
            <day>15</day>
            <volume>116</volume>
            <issue>5</issue>
            <fpage>533</fpage>
            <page-range>533-47</page-range>
            <pub-id pub-id-type="pmid">8238212</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McCord</surname>
                <given-names>CD</given-names>
              </name>
            </person-group>
            <article-title>Orbital decompression for Graves' disease. Exposure through lateral canthal and inferior fornix incision.</article-title>
            <source>Ophthalmology</source>
            <year>1981</year>
            <month>Jun</month>
            <volume>88</volume>
            <issue>6</issue>
            <fpage>533</fpage>
            <page-range>533-41</page-range>
            <pub-id pub-id-type="pmid">6894974</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leone</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Bajandas</surname>
                <given-names>FJ</given-names>
              </name>
            </person-group>
            <article-title>Inferior orbital decompression for thyroid ophthalmopathy.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1980</year>
            <month>May</month>
            <volume>98</volume>
            <issue>5</issue>
            <fpage>890</fpage>
            <page-range>890-2</page-range>
            <pub-id pub-id-type="pmid">6892879</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Timoney</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Sokol</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Hauck</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>Nunery</surname>
                <given-names>WR</given-names>
              </name>
            </person-group>
            <article-title>Transcutaneous medial canthal tendon incision to the medial orbit.</article-title>
            <source>Ophthalmic Plast Reconstr Surg</source>
            <year>2012</year>
            <season>Mar-Apr</season>
            <volume>28</volume>
            <issue>2</issue>
            <fpage>140</fpage>
            <page-range>140-4</page-range>
            <pub-id pub-id-type="pmid">22410662</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Perry</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Kadakia</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Transcaruncular orbital decompression for dysthyroid optic neuropathy.</article-title>
            <source>Ophthalmic Plast Reconstr Surg</source>
            <year>2003</year>
            <month>Sep</month>
            <volume>19</volume>
            <issue>5</issue>
            <fpage>353</fpage>
            <page-range>353-8</page-range>
            <pub-id pub-id-type="pmid">14506419</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shorr</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Baylis</surname>
                <given-names>HI</given-names>
              </name>
              <name>
                <surname>Goldberg</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Perry</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Transcaruncular approach to the medial orbit and orbital apex.</article-title>
            <source>Ophthalmology</source>
            <year>2000</year>
            <month>Aug</month>
            <volume>107</volume>
            <issue>8</issue>
            <fpage>1459</fpage>
            <page-range>1459-63</page-range>
            <pub-id pub-id-type="pmid">10919889</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goldberg</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Perry</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Hortaleza</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Tong</surname>
                <given-names>JT</given-names>
              </name>
            </person-group>
            <article-title>Strabismus after balanced medial plus lateral wall versus lateral wall only orbital decompression for dysthyroid orbitopathy.</article-title>
            <source>Ophthalmic Plast Reconstr Surg</source>
            <year>2000</year>
            <month>Jul</month>
            <volume>16</volume>
            <issue>4</issue>
            <fpage>271</fpage>
            <page-range>271-7</page-range>
            <pub-id pub-id-type="pmid">10923974</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lv</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Selva</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Yan</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Daniel</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Tu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Endoscopical Orbital Fat Decompression with Medial Orbital Wall Decompression for Dysthyroid Optic Neuropathy.</article-title>
            <source>Curr Eye Res</source>
            <year>2016</year>
            <volume>41</volume>
            <issue>2</issue>
            <fpage>150</fpage>
            <page-range>150-8</page-range>
            <pub-id pub-id-type="pmid">25835075</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124988.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Donaldson</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Bagshaw</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Kriss</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Supervoltage orbital radiotherapy for Graves' ophthalmopathy.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>1973</year>
            <month>Aug</month>
            <volume>37</volume>
            <issue>2</issue>
            <fpage>276</fpage>
            <page-range>276-85</page-range>
            <pub-id pub-id-type="pmid">4198257</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
